Back

prof. dr. M. (Miriam) Koopman

prof. dr. M. (Miriam) Koopman

Full Professor

Show full profile

Research Output (219)

Cost-effectiveness in colorectal cancer: challenges on quality and comparability

Franken Mira, Rooijen EM, Uyl-de Groot C.A., Van Oijen Martijn Gh, Koopman M 4 Feb 2016, In: Colorectal Cancer.

Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy:an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database

Franko Jan, Shi Qian, Meyers Jeffrey P., Maughan Timothy S., Adams Richard A., Seymour Matthew T., Saltz Leonard, Punt Cornelis J A, Koopman Miriam, Tournigand Christophe, Tebbutt Niall C., Diaz-Rubio Eduardo, Souglakos John, Falcone Alfredo, Chibaudel Benoist, Heinemann Volker, Moen Joseph, De Gramont Aimery, Sargent Daniel J., Grothey Axel 2016, In: LANCET ONCOLOGY. 17 , p. 1709–1719 11 p.

Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity:a systematic review and meta-analysis of individual patient data

Meulendijks Didier, Henricks Linda M, Sonke Gabe S, Deenen Maarten J, Froehlich Tanja K, Amstutz Ursula, Largiadèr Carlo R, Jennings Barbara A, Marinaki Anthony M, Sanderson Jeremy D, Kleibl Zdenek, Kleiblova Petra, Schwab Matthias, Zanger Ulrich M, Palles Claire, Tomlinson Ian, Gross Eva, van Kuilenburg André B P, Punt Cornelis J A, Koopman Miriam, Beijnen Jos H, Cats Annemieke, Schellens Jan H M Dec 2015, In: LANCET ONCOLOGY. 16 , p. 1639-1650 12 p.

Maintenance treatment in metastatic colorectal cancer

Simkens Lieke H J, van Tinteren Harm, Punt Cornelis J A, Koopman Miriam Dec 2015, In: LANCET ONCOLOGY. 16 , p. e582–e583

Reduced rate of copy number aberrations in mucinous colorectal carcinoma

Hugen Niek, Simmer Femke, Mekenkamp Leonie J M, Koopman Miriam, van den Broek Evert, de Wilt Johannes H W, Punt Cornelis J A, Ylstra Bauke, Meijer Gerrit A, Nagtegaal Iris D 22 Sep 2015, In: Oncotarget. 6 , p. 25715-25725 11 p.

MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer

Simmer Femke, Venderbosch Sabine, Dijkstra Jeroen R, Vink-Börger Elisa M, Faber Claudius, Mekenkamp Leonie J, Koopman Miriam, De Haan Anton F, Punt Cornelis J, Nagtegaal Iris D 8 Sep 2015, In: Oncotarget. 6 , p. 22996-23007 12 p.

Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases

van der Geest Lydia G M, Lam-Boer Jorine't, Koopman Miriam, Verhoef Cees, Elferink Marloes A G, de Wilt Johannes H W Jun 2015, In: Clinical & Experimental Metastasis. 32 , p. 457-465 9 p.

Mitochondrial microsatellite instability in patients with metastatic colorectal cancer

Venderbosch S., van Vliet S., Craenmehr M. H C, Simmer F., de Haan A. F J, Punt C. J A, Koopman M., Nagtegaal I. D. 1 May 2015, In: Virchows Archives. 466 , p. 495-502 8 p.

RandomizEd controlled trial for pre-operAtive dose-escaLation BOOST in locally advanced rectal cancer (RECTAL BOOST study):study protocol for a randomized controlled trial

Burbach J. P. Maarten , Verkooijen Helena M., Intven Martijn, Kleijnen Jean-Paul J. E., Bosman Mirjam E., Raaymakers Bas W., van Grevenstein Wilhelmina M. U., Koopman Miriam, Seravalli Enrica, van Asselen B, Reerink Onne 22 Feb 2015, In: Trials [E]. 16 8 p.

ABC-transporter expression does not correlate with response to irinotecan in patients with metastatic colorectal cancer

Trumpi K., Emmink B. L., Prins A. M., van Oijen M. G H, van Diest P. J., Punt C. J A, Koopman M., Kranenburg O., Borel Rinkes I. H M 2015, In: British Journal of Cancer. 6 , p. 1079-1086 8 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not